Progress in Regenerative Medicine: Exploring Autologous Platelet Concentrates and Their Clinical Applications.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing autologous platelet concentrate types without systematic search or meta-analysis
PubMed 37761809 · doi:10.3390/genes14091669
What was done
This review examined autologous platelet concentrate (APC) modalities used in regenerative medicine. The authors analyzed three generations of concentrates—platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factors (CGFs)—comparing their preparation methods, structural characteristics, growth factor and leukocyte compositions, level of biological characterization, and clinical applications.
What was found
The abstract provides a qualitative overview and reports no quantitative data, comparative effect estimates, or statistical outcomes.
Why it matters
Autologous platelet concentrates offer a minimally invasive alternative to stem cell therapies and tissue grafts by leveraging patient-derived growth factors to support tissue repair and regeneration.
Limits
The abstract describes a non-systematic narrative review without specified search criteria, study selection filters, or meta-analytic synthesis. No quantitative efficacy comparisons, patient-level outcome metrics, or sample sizes are reported.
Cited by
- supports Platelet-rich plasma does not contain stem cells.